GlassScriptPhysician profile
Joshua Nelson
NPI 1669811121
$3,180.18
in general payments reported to CMS, 2019-2025
11 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $185 · 2021: $541 · 2022: $936 · 2023: $349 · 2024: $635 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159 · Long Term Medical Supply Or Device Loan: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.64 |
| Long Term Medical Supply Or Device Loan | $215.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $809.87 | 2020-2025 | Integra, Cytal, Primatrix |
| Sientra, INC. | $677.46 | 2021-2022 | |
| Davol INC. | $474.89 | 2022-2025 | Phasix Mesh |
| Axogen | $403.83 | 2021-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Mentor Worldwide LLC | $376.31 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Musculoskeletal Transplant Foundation INC. | $194.35 | 2019-2020 | |
| Tela Bio, INC. | $157.77 | 2024 | Ovitex 2s |
| Boston Scientific Corporation | $25.45 | 2024 | |
| Abbott Laboratories | $23.05 | 2023 | Cardiomems |
| Becton, Dickinson and Company | $21.98 | 2023 | |
| Kerecis Limited | $15.22 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.